前沿生物(688221.SH)：继续使用不超3亿元闲置募集资金暂时补充流动资金

Core Points - Frontier Biotech (688221.SH) announced the approval of a proposal to temporarily use part of its idle raised funds to supplement working capital [1] - The company will utilize no more than RMB 300 million (including 300 million) of idle funds from its initial public offering for this purpose [1] - The usage period for these funds is set to be no more than 12 months from the date of the board's approval of the proposal, ensuring that it does not affect the progress of the investment projects funded by the raised capital [1]